DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer

Autoria(s): Hill, L. A.; Mulligan, J. M.; Deharo, S.; Keating, K. E.; McDyer, F. A.; Davison, T. S.; Gourley, C.; Harkin, D. P.; Kennedy, R. D.
Data(s)

01/09/2013
Identificador

http://pure.qub.ac.uk/portal/en/publications/dna-damage-response-deficiency-signature-predicts-response-to-platinumbased-therapy-in-ovarian-cancer(690f0887-b85f-4a36-b21a-385e9ad241f4).html
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Hill , L A , Mulligan , J M , Deharo , S , Keating , K E , McDyer , F A , Davison , T S , Gourley , C , Harkin , D P & Kennedy , R D 2013 , ' DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer ' European Journal of Cancer , vol 49 , no. 2 , pp. S196-S196 .
Tipo

article
Acesso ao item digital